Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Allegheny Technologies Inc. (NYSE: ATI) shares gained 3.20 percent to close at $33.82 a share Monday. The stock traded between $33.10 and $33.88 on volume of 1.23 million shares traded. Analysts at Buckingham have recently upgraded the company’s rating to “buy” from "hold". Shares of Allegheny Technologies have gained approximately 11.0 percent year-to-date.
Find out more about Allegheny Technologies including full access to the free equity report at:
www.RDInvesting.com/ATI
Ceragon Networks Ltd. (NASDAQ: CRNT) shares gained 6.75 percent to close at $2.69 a share Monday. The stock traded between $2.65 and $2.82 on volume of 1.73 million shares traded. Analysts at Needham have recently initiated coverage on the company with a "strong buy" rating. Shares of Ceragon Networks have fallen approximately 40.0 percent year-to-date.
Find out more about Ceragon Networks including full access to the free equity report at:
www.RDInvesting.com/CRNT
Mellanox Technologies, Ltd. (NASDAQ: MLNX) shares declined 0.33 percent to close at $39.03 a share Monday. The stock traded between $38.92 and $41.38 on volume of 977,873 shares traded. Analysts at Maxim Group have recently upgraded the company’s rating to "buy" from "hold". Shares of Mellanox Technologies have fallen approximately 34.0 percent year-to-date.
Find out more about Mellanox Technologies including full access to the free equity report at:
www.RDInvesting.com/MLNX
OmniVision Technologies, Inc. (NASDAQ: OVTI) shares gained 1.09 percent to close at $15.78 a share Monday. The stock traded between $15.51 and $15.92 on volume of 1.10 million shares traded. Analysts at Cross Research have recently initiated coverage on the company with a "hold" rating. Shares of OmniVision Technologies have gained approximately 12.0 percent year-to-date.
Find out more about OmniVision Technologies including full access to the free equity report at:
www.RDInvesting.com/OVTI
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]